Shipra Agrawal
Overview
Explore the profile of Shipra Agrawal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1010
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Agrawal S, Brier M, Kerlin B, Smoyer W
Kidney Int Rep
. 2021 Mar;
6(3):785-795.
PMID: 33732993
Introduction: Glucocorticoids (GCs) are the primary treatment for nephrotic syndrome (NS), although ∼10% to 20% of children develop steroid-resistant NS (SRNS). Unfortunately, there are no validated biomarkers able to predict...
12.
Murugan N, Kandasamy D, Sharma R, Goyal A, Gupta A, Tandon N, et al.
Eur J Radiol
. 2021 Mar;
138:109625.
PMID: 33714845
Background: Minimally invasive parathyroid surgery is the standard of care in patients with Primary Hyperparathyroidism (PHPT) which requires accurate preoperative localization. Of all the available imaging modalities, 4DCT is considered...
13.
Agrawal S, Ransom R, Saraswathi S, Garcia-Gonzalo E, Webb A, Fernandez-Martinez J, et al.
J Clin Med
. 2021 Feb;
10(3).
PMID: 33540508
Glucocorticoid (GC) resistance complicates the treatment of ~10-20% of children with nephrotic syndrome (NS), yet the molecular basis for resistance remains unclear. We used RNAseq analysis and in silico algorithm-based...
14.
Agrawal S, He J, Tharaux P
Nat Rev Nephrol
. 2020 Sep;
17(3):185-204.
PMID: 32943753
Nuclear receptors have a broad spectrum of biological functions in normal physiology and in the pathology of various diseases, including glomerular disease. The primary therapies for many glomerular diseases are...
15.
Waller A, Agrawal S, Wolfgang K, Kino J, Chanley M, Smoyer W, et al.
Physiol Rep
. 2020 Aug;
8(15):e14515.
PMID: 32776495
Background: Thrombosis is a potentially life-threatening nephrotic syndrome (NS) complication. We have previously demonstrated that hypercoagulopathy is proportional to NS severity in rat models and that pioglitazone (Pio) reduces proteinuria...
16.
Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics
Gooding J, Agrawal S, McRitchie S, Acuff Z, Merchant M, Klein J, et al.
Kidney Int Rep
. 2020 Jan;
5(1):81-93.
PMID: 31922063
Introduction: Nephrotic syndrome (NS) is a kidney disease that affects both children and adults. Glucocorticoids have been the primary therapy for >60 years but are ineffective in approximately 20% of...
17.
Agrawal S, Merchant M, Kino J, Li M, Wilkey D, Gaweda A, et al.
Kidney Int Rep
. 2020 Jan;
5(1):66-80.
PMID: 31922062
Introduction: Nephrotic syndrome (NS) is a characterized by massive proteinuria, edema, hypoalbuminemia, and dyslipidemia. Glucocorticoids (GCs), the primary therapy for >60 years, are ineffective in approximately 50% of adults and...
18.
Agrawal S, Zaritsky J, Fornoni A, Smoyer W
Nat Rev Nephrol
. 2017 Dec;
14(1):70.
PMID: 29234164
This corrects the article DOI: 10.1038/nrneph.2017.155.
19.
Nie X, Chanley M, Pengal R, Thomas D, Agrawal S, Smoyer W
Am J Physiol Renal Physiol
. 2017 Dec;
314(4):F602-F613.
PMID: 29187369
Nie X, Chanley MA, Pengal R, Thomas DB, Agrawal S, Smoyer WE. Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome. Am J Physiol Renal...
20.
Agrawal S, Zaritsky J, Fornoni A, Smoyer W
Nat Rev Nephrol
. 2017 Nov;
14(1):57-70.
PMID: 29176657
Nephrotic syndrome is a highly prevalent disease that is associated with high morbidity despite notable advances in its treatment. Many of the complications of nephrotic syndrome, including the increased risk...